|
DE19856475A1
(de)
*
|
1998-11-27 |
2000-05-31 |
Schering Ag |
Nichtsteroidale Entzündungshemmer
|
|
DE10346940B3
(de)
*
|
2003-10-06 |
2005-06-16 |
Schering Ag |
Substituierte Pentanole, ihre Verwendung zur Herstellung von Arzneimitteln speziell Entzündungshemmer sowie diese enthaltende pharmazeutische Präparate
|
|
DE10038639A1
(de)
|
2000-07-28 |
2002-02-21 |
Schering Ag |
Nichtsteroidale Entzündungshemmer
|
|
WO2002054064A2
(en)
*
|
2000-12-28 |
2002-07-11 |
Schering Ag |
Method for screening for progesterone receptor isoform-specific ligands
|
|
CA2472746A1
(en)
*
|
2002-01-14 |
2003-07-24 |
Boehringer Ingelheim Pharmaceuticals, Inc. |
Glucocorticoid mimetics, methods of making them, pharmaceutical formulations containing them and uses thereof
|
|
JP2005526064A
(ja)
*
|
2002-03-11 |
2005-09-02 |
シエーリング アクチエンゲゼルシャフト |
受精能制御およびホルモン置換療法における使用のためのプロゲステロン受容体調整活性を有する５−｛２−ヒドロキシ−３−１−（３−トリフルオロメチルフェニル）−シクロプロピル−プロピオニルアミノ｝−フタリドおよび関連化合物
|
|
EP1344776A1
(en)
*
|
2002-03-11 |
2003-09-17 |
Schering Aktiengesellschaft |
5- 2-hydroxy-3-[1-(3-trifluoromethylphenyl)-cyclopropyl]-propionylamino -phtalide and 6- 2-hydroxy-3-[1-(3-trifluoromethylphenyl)-cyclopropyl]-propionylamino -4-methyl-2,3-benzoxazin-1-one derivatives with progesterone receptor modulating activity for use in fertility control, hormone replacement therapy and the treatment of gynecological disorders
|
|
UA80120C2
(en)
|
2002-03-26 |
2007-08-27 |
Boehringer Ingelheim Pharma |
Glucocorticoid mimetics, pharmaceutical composition based thereon
|
|
CA2477764A1
(en)
|
2002-03-26 |
2003-10-09 |
Boehringer Ingelheim Pharmaceuticals, Inc. |
Glucocorticoid mimetics, methods of making them, pharmaceutical compositions, and uses thereof
|
|
DE10215316C1
(de)
*
|
2002-04-02 |
2003-12-18 |
Schering Ag |
Chinolin- und Isochinolin-Derivate, ein pharmazeutisches Mittel und ihre Verwendung als Entzündungshemmer
|
|
US7186864B2
(en)
|
2002-05-29 |
2007-03-06 |
Boehringer Ingelheim Pharmaceuticals, Inc. |
Glucocorticoid mimetics, methods of making them, pharmaceutical compositions, and uses thereof
|
|
US7074806B2
(en)
|
2002-06-06 |
2006-07-11 |
Boehringer Ingelheim Pharmaceuticals, Inc. |
Glucocorticoid mimetics, methods of making them, pharmaceutical compositions, and uses thereof
|
|
CA2496175A1
(en)
|
2002-08-21 |
2004-03-04 |
Boehringer Ingelheim Pharmaceuticals, Inc. |
Substituted hihydroquinolines as glucocorticoid mimetics, methods of making them, pharmaceutical compositions, and uses thereof
|
|
EA011095B1
(ru)
|
2002-08-29 |
2008-12-30 |
Бёрингер Ингельхайм Фармасьютиклз, Инк. |
Производные 3-(сульфонамидоэтил)индола, предназначенные для использования в качестве миметиков глюкокортикоидов при лечении воспалительных, аллергических и пролиферативных заболеваний
|
|
JP2006518328A
(ja)
*
|
2002-10-15 |
2006-08-10 |
ユニバーシティ・オブ・テネシー・リサーチ・ファウンデーション |
複素環選択的アンドロゲン受容体調節剤及びその使用方法
|
|
DE10261874A1
(de)
*
|
2002-12-20 |
2004-07-08 |
Schering Ag |
Nichtsteroidale Entzündungshemmer
|
|
CA2512257A1
(en)
|
2003-01-03 |
2004-07-29 |
Boehringer Ingelheim Pharmaceuticals, Inc. |
1-propanol and 1-propylamine derivatives and their use as glucocorticoid ligands
|
|
US20040224992A1
(en)
*
|
2003-02-27 |
2004-11-11 |
Boehringer Ingelheim Pharmaceuticals, Inc. |
Glucocorticoid mimetics, methods of making them, pharmaceutical compositions, and uses thereof
|
|
EP1638945A1
(de)
*
|
2003-07-01 |
2006-03-29 |
Schering Aktiengesellschaft |
Heterozyklisch substituierte pentanol-derivate, verfahren zu ihrer herstellung und ihre verwendung als entz ndungshemmer
|
|
GB0316290D0
(en)
|
2003-07-11 |
2003-08-13 |
Glaxo Group Ltd |
Novel compounds
|
|
UY28526A1
(es)
|
2003-09-24 |
2005-04-29 |
Boehringer Ingelheim Pharma |
Miméticos de glucocorticoides, métodos de preparación composiciones farmacéuticas y usos de los mismos
|
|
ES2290769T3
(es)
|
2003-10-16 |
2008-02-16 |
Boehringer Ingelheim Pharmaceuticals Inc. |
Sintesis estereoselectiva de ciertos alcoholes substituidos con trifluormetilo.
|
|
US7795272B2
(en)
|
2004-03-13 |
2010-09-14 |
Boehringer Ingelheim Pharmaceutical, Inc. |
Glucocorticoid mimetics, methods of making them, pharmaceutical compositions and uses thereof
|
|
AR049384A1
(es)
|
2004-05-24 |
2006-07-26 |
Glaxo Group Ltd |
Derivados de purina
|
|
TWI307630B
(en)
|
2004-07-01 |
2009-03-21 |
Glaxo Group Ltd |
Immunoglobulins
|
|
DE102004062182B4
(de)
*
|
2004-12-20 |
2007-06-06 |
Bayer Schering Pharma Ag |
Transdermales Pflaster mit Progesteron A-Spezifische Liganden (PRASL) als Wirkstoff
|
|
PE20060776A1
(es)
|
2004-12-27 |
2006-09-26 |
Boehringer Ingelheim Pharma |
Mimeticos de glucocorticoides, metodos para prepararlos y composiciones farmaceuticas
|
|
EP1841780B1
(en)
|
2005-01-10 |
2011-07-27 |
Glaxo Group Limited |
Androstane 17-alpha-carbonate derivatives for use in the treatment of allergic and inflammatory conditions
|
|
WO2006083030A1
(ja)
*
|
2005-02-04 |
2006-08-10 |
Ajinomoto Co., Inc. |
脂肪酸の製造方法および脂肪酸の塩結晶
|
|
UY29440A1
(es)
|
2005-03-25 |
2006-10-02 |
Glaxo Group Ltd |
Nuevos compuestos
|
|
UY29439A1
(es)
|
2005-03-25 |
2006-10-02 |
Glaxo Group Ltd |
Nuevos compuestos
|
|
DE102005017326A1
(de)
*
|
2005-04-14 |
2007-03-29 |
Schering Ag |
Tetrahydronaphthalinderivate, Verfahren zu ihrer Herstellung und ihre Verwendung als Entzündungshemmer
|
|
US7408060B2
(en)
|
2005-06-24 |
2008-08-05 |
Schering Ag |
Nonsteroidal progesterone receptor modulators
|
|
DE102005030293A1
(de)
*
|
2005-06-24 |
2007-01-04 |
Schering Ag |
Verwendung von nichtsteroidale Progesteronrezeptor-Modulatoren
|
|
DE102005030294A1
(de)
*
|
2005-06-24 |
2007-01-04 |
Schering Ag |
Nichtsteroidale Progesteronrezeptor-Modulatoren
|
|
GB0514809D0
(en)
|
2005-07-19 |
2005-08-24 |
Glaxo Group Ltd |
Compounds
|
|
BRPI0619518A2
(pt)
*
|
2005-12-09 |
2011-10-11 |
Hoffmann La Roche |
moduladores do receptor de glicocorticoide, composição farmacêutica que os compreende e usos dos mesmos
|
|
TW200730498A
(en)
|
2005-12-20 |
2007-08-16 |
Glaxo Group Ltd |
Compounds
|
|
MX2008013411A
(es)
|
2006-04-20 |
2008-11-04 |
Glaxo Group Ltd |
Nuevos compuestos.
|
|
GB0611587D0
(en)
|
2006-06-12 |
2006-07-19 |
Glaxo Group Ltd |
Novel compounds
|
|
EP2102170A2
(en)
|
2006-12-06 |
2009-09-23 |
Boehringer Ingelheim International GmbH |
Glucocorticoid mimetics, methods of making them, pharmaceutical compositions, and uses thereof
|
|
UY30805A1
(es)
*
|
2006-12-21 |
2008-07-31 |
Bayer Schering Pharma Ag |
Moduladores no esteroides de receptores de progesterona
|
|
DE102007049630A1
(de)
|
2007-10-11 |
2009-10-29 |
Bayer Schering Pharma Aktiengesellschaft |
Nichtsteroidale Progesteronrezeptor-Modulatoren
|
|
UY30815A1
(es)
*
|
2006-12-21 |
2008-07-31 |
Bayer Schering Pharma Ag |
Moduladores no esteroidales del receptor de progesterona
|
|
DE102007023614A1
(de)
|
2007-05-21 |
2008-11-27 |
Bayer Schering Pharma Aktiengesellschaft |
Nichtsteroidale Progesteronrezeptor-Modulatoren
|
|
JP5090773B2
(ja)
*
|
2006-12-26 |
2012-12-05 |
国立大学法人東京工業大学 |
光学活性含フッ素カルボニル−エン生成物の製造方法
|
|
PE20081889A1
(es)
|
2007-03-23 |
2009-03-05 |
Smithkline Beecham Corp |
Indol carboxamidas como inhibidores de ikk2
|
|
DE102007032800A1
(de)
|
2007-07-10 |
2009-01-15 |
Bayer Schering Pharma Aktiengesellschaft |
Nichtsteroidale Progesteronrezeptor-Modulatoren
|
|
DE102007058747A1
(de)
|
2007-12-05 |
2009-06-10 |
Bayer Schering Pharma Aktiengesellschaft |
Nichtsteroidale Progesteronrezeptor-Modulatoren
|
|
EP2070909A1
(de)
*
|
2007-12-15 |
2009-06-17 |
Bayer Schering Pharma AG |
Nichtsteroidale Progesteronrezeptor-Modulatoren
|
|
JP5791500B2
(ja)
|
2008-05-23 |
2015-10-07 |
パンミラ ファーマシューティカルズ，エルエルシー． |
５−リポキシゲナーゼ活性化タンパク質阻害剤
|
|
ES2566339T3
(es)
|
2008-06-05 |
2016-04-12 |
Glaxo Group Limited |
Derivados de 4-carboxamida indazol útiles como inhibidores de PI3-quinasas
|
|
ES2383246T3
(es)
|
2008-06-05 |
2012-06-19 |
Glaxo Group Limited |
4-amino-indazoles
|
|
CA2726449A1
(en)
|
2008-06-06 |
2009-12-10 |
Boehringer Ingelheim International Gmbh |
Glucocorticoid mimetics, methods of making them, pharmaceutical compositions, and uses thereof
|
|
WO2010094643A1
(en)
|
2009-02-17 |
2010-08-26 |
Glaxo Group Limited |
Quinoline derivatives and their uses for rhinitis and urticaria
|
|
JP5656880B2
(ja)
|
2009-03-09 |
2015-01-21 |
グラクソ グループ リミテッドＧｌａｘｏ Ｇｒｏｕｐ Ｌｉｍｉｔｅｄ |
Ｐｉ３キナーゼの阻害剤としての４−オキサジアゾール−２−イル−インダゾール
|
|
WO2010102968A1
(en)
|
2009-03-10 |
2010-09-16 |
Glaxo Group Limited |
Indole derivatives as ikk2 inhibitors
|
|
WO2010106016A1
(en)
|
2009-03-17 |
2010-09-23 |
Glaxo Group Limited |
Pyrimidine derivatives used as itk inhibitors
|
|
EP2408458A1
(en)
|
2009-03-19 |
2012-01-25 |
Merck Sharp&Dohme Corp. |
RNA INTERFERENCE MEDIATED INHIBITION OF SIGNAL TRANSDUCER AND ACTIVATOR OF TRANSCRIPTION 6 (STAT6) GENE EXPRESSION USING SHORT INTERFERING NUCLEIC ACID (siNA)
|
|
WO2010107952A2
(en)
|
2009-03-19 |
2010-09-23 |
Merck Sharp & Dohme Corp. |
RNA INTERFERENCE MEDIATED INHIBITION OF CONNECTIVE TISSUE GROWTH FACTOR (CTGF) GENE EXPRESSION USING SHORT INTERFERING NUCLEIC ACID (siNA)
|
|
EP2408915A2
(en)
|
2009-03-19 |
2012-01-25 |
Merck Sharp&Dohme Corp. |
RNA INTERFERENCE MEDIATED INHIBITION OF GATA BINDING PROTEIN 3 (GATA3) GENE EXPRESSION USING SHORT INTERFERING NUCLEIC ACID (siNA)
|
|
EP2408917A2
(en)
|
2009-03-19 |
2012-01-25 |
Merck Sharp&Dohme Corp. |
RNA INTERFERENCE MEDIATED INHIBITION OF BTB AND CNC HOMOLOGY 1, BASIC LEUCINE ZIPPER TRANSCRIPTION FACTOR 1 (BACH 1) GENE EXPRESSION USING SHORT INTERFERING NUCLEIC ACID (siNA) SEQUENCE LISTING
|
|
US20120004281A1
(en)
|
2009-03-27 |
2012-01-05 |
Merck Sharp & Dohme Corp |
RNA Interference Mediated Inhibition of the Nerve Growth Factor Beta Chain (NGFB) Gene Expression Using Short Interfering Nucleic Acid (siNA)
|
|
WO2010111471A2
(en)
|
2009-03-27 |
2010-09-30 |
Merck Sharp & Dohme Corp. |
RNA INTERFERENCE MEDIATED INHIBITION OF SIGNAL TRANSDUCER AND ACTIVATOR OF TRANSCRIPTION 1 (STAT1) GENE EXPRESSION USING SHORT INTERFERING NUCLEIC ACID (siNA)
|
|
JP2012521764A
(ja)
|
2009-03-27 |
2012-09-20 |
メルク・シャープ・エンド・ドーム・コーポレイション |
低分子干渉核酸（ｓｉＮＡ）を用いた胸腺間質性リンパ球新生因子（ＴＳＬＰ）遺伝子発現のＲＮＡ干渉媒介性阻害
|
|
AU2010229847A1
(en)
|
2009-03-27 |
2011-10-13 |
Merck Sharp & Dohme Corp. |
RNA interference mediated inhibition of the intercellular adhesion molecule 1 (ICAM-1)gene expression using short interfering nucleic acid (siNA)
|
|
JP2012521760A
(ja)
|
2009-03-27 |
2012-09-20 |
メルク・シャープ・エンド・ドーム・コーポレイション |
低分子干渉核酸（ｓｉＮＡ）を用いたアポトーシスシグナル調節キナーゼ１（ＡＳＫ１）遺伝子発現のＲＮＡ干渉媒介性阻害
|
|
WO2010122088A1
(en)
|
2009-04-24 |
2010-10-28 |
Glaxo Group Limited |
Pyrazole and triazole carboxamides as crac channel inhibitors
|
|
UY32571A
(es)
|
2009-04-24 |
2010-11-30 |
Glaxo Group Ltd |
Compuestos derivados de pirazol amida
|
|
WO2010125082A1
(en)
|
2009-04-30 |
2010-11-04 |
Glaxo Group Limited |
Oxazole substituted indazoles as pi3-kinase inhibitors
|
|
EP2507226A1
(en)
|
2009-12-03 |
2012-10-10 |
Glaxo Group Limited |
Novel compounds
|
|
US20120245171A1
(en)
|
2009-12-03 |
2012-09-27 |
Glaxo Group Limited |
Benzpyrazole derivatives as inhibitors of pi3 kinases
|
|
EP2507231A1
(en)
|
2009-12-03 |
2012-10-10 |
Glaxo Group Limited |
Indazole derivatives as pi 3 - kinase inhibitors
|
|
EP2512438B1
(en)
|
2009-12-16 |
2017-01-25 |
3M Innovative Properties Company |
Formulations and methods for controlling mdi particle size delivery
|
|
WO2011110575A1
(en)
|
2010-03-11 |
2011-09-15 |
Glaxo Group Limited |
Derivatives of 2-[2-(benzo- or pyrido-) thiazolylamino]-6-aminopyridine, useful in the treatment of respiratoric, allergic or inflammatory diseases
|
|
GB201007203D0
(en)
|
2010-04-29 |
2010-06-16 |
Glaxo Group Ltd |
Novel compounds
|
|
RS54286B1
(sr)
|
2010-09-08 |
2016-02-29 |
Glaxosmithkline Intellectual Property Development Limited |
Polimorfi i soli n-[5-[4-(5-{[(2r,6s)-2,6-dimetil-4-morfolinil]metil}-1,3-oksazol-2-il)-1h-indazol-6-il]-2(metiloksi)-3-piridinil]-metansulfonamida
|
|
US9326987B2
(en)
|
2010-09-08 |
2016-05-03 |
Glaxo Group Limited |
Indazole derivatives for use in the treatment of influenza virus infection
|
|
WO2012035055A1
(en)
|
2010-09-17 |
2012-03-22 |
Glaxo Group Limited |
Novel compounds
|
|
ES2532213T3
(es)
|
2010-10-21 |
2015-03-25 |
Glaxo Group Limited |
Compuestos de pirazol que actúan contra afecciones alérgicas, inmunitarias e inflamatorias
|
|
US9149462B2
(en)
|
2010-10-21 |
2015-10-06 |
Glaxo Group Limited |
Pyrazole compounds acting against allergic, inflammatory and immune disorders
|
|
GB201018124D0
(en)
|
2010-10-27 |
2010-12-08 |
Glaxo Group Ltd |
Polymorphs and salts
|
|
US20140005188A1
(en)
|
2011-03-11 |
2014-01-02 |
Glaxo Group Limited |
Pyrido[3,4-b]pyrazine derivatives as syk inhibitors
|
|
GB201104153D0
(en)
|
2011-03-11 |
2011-04-27 |
Glaxo Group Ltd |
Novel compounds
|
|
US9657007B2
(en)
|
2013-09-22 |
2017-05-23 |
Calitor Sciences, Llc |
Substituted aminopyrimidine compounds and methods of use
|
|
KR20160062178A
(ko)
|
2013-10-17 |
2016-06-01 |
글락소스미스클라인 인털렉츄얼 프로퍼티 디벨로프먼트 리미티드 |
호흡기 질병의 치료를 위한 ｐｉ３ｋ 억제제
|
|
JP2016537327A
(ja)
|
2013-10-17 |
2016-12-01 |
グラクソスミスクライン、インテレクチュアル、プロパティー、ディベロップメント、リミテッドＧｌａｘｏｓｍｉｔｈｋｌｉｎｅ Ｉｎｔｅｌｌｅｃｔｕａｌ Ｐｒｏｐｅｒｔｙ Ｄｅｖｅｌｏｐｍｅｎｔ Ｌｉｍｉｔｅｄ |
呼吸器疾患の治療のためのｐｉ３ｋ阻害剤
|
|
MX2016012574A
(es)
|
2014-03-28 |
2017-09-26 |
Calitor Sciences Llc |
Compuestos heteroarilo sustituidos y metodos de uso.
|
|
US20170100385A1
(en)
|
2014-05-12 |
2017-04-13 |
Glaxosmithkline Intellectual Property (No. 2) Limited |
Pharmaceutical compositions comprising danirixin for treating infectious diseases
|
|
WO2017044434A1
(en)
|
2015-09-11 |
2017-03-16 |
Sunshine Lake Pharma Co., Ltd. |
Substituted heteroaryl compounds and methods of use
|
|
GB201602527D0
(en)
|
2016-02-12 |
2016-03-30 |
Glaxosmithkline Ip Dev Ltd |
Chemical compounds
|
|
WO2018029126A1
(en)
|
2016-08-08 |
2018-02-15 |
Glaxosmithkline Intellectual Property Development Limited |
Chemical compounds
|
|
GB201706102D0
(en)
|
2017-04-18 |
2017-05-31 |
Glaxosmithkline Ip Dev Ltd |
Chemical compounds
|
|
GB201712081D0
(en)
|
2017-07-27 |
2017-09-13 |
Glaxosmithkline Ip Dev Ltd |
Chemical compounds
|
|
EP3569228A1
(en)
*
|
2018-05-17 |
2019-11-20 |
Association pour la recherche à l'IGBMC (ARI) |
Non-steroidal selective glucocorticoid receptor agonistic modulators (segrams) and uses thereof
|
|
US10683297B2
(en)
|
2017-11-19 |
2020-06-16 |
Calitor Sciences, Llc |
Substituted heteroaryl compounds and methods of use
|
|
AU2019209960B2
(en)
|
2018-01-20 |
2023-11-23 |
Sunshine Lake Pharma Co., Ltd. |
Substituted aminopyrimidine compounds and methods of use
|
|
BR112022019245A2
(pt)
|
2020-03-26 |
2022-11-16 |
Glaxosmithkline Ip Dev Ltd |
Inibidores de catepsina para prevenir ou tratar infecções virais
|
|
CN113801098B
(zh)
*
|
2020-06-12 |
2023-05-30 |
上海济煜医药科技有限公司 |
酞嗪酮类化合物及其制备方法和医药用途
|
|
CN114605308B
(zh)
*
|
2022-03-18 |
2023-12-19 |
阜新孚隆宝医药科技有限公司 |
一种帕罗韦德的氮杂双环医药中间体的制备方法及中间体
|